Fig. 2From: Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantationBoth WT1 transcript level and C-KIT mutation at diagnosis were associated with outcomes in patients who received chemotherapy only. Patients were grouped by WT1 transcript level and/or C-KIT mutation at diagnosis. a, d, g cumulative incidence of relapse (CIR) rate (%); b, e, h leukemia-free survival (LFS) rate (%); c, f, i overall survival (OS) rate (%). Each row has the same labels that are shown on the right of the row Back to article page